These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6541243)
21. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum]. Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567 [TBL] [Abstract][Full Text] [Related]
22. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum. Storch E; Baumgartl D; Kirchner H Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572 [TBL] [Abstract][Full Text] [Related]
23. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
24. Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum. Gusdon JP; Homesley HD; Jobson VW; Muss HB Obstet Gynecol; 1983 Dec; 62(6):728-35. PubMed ID: 6633998 [TBL] [Abstract][Full Text] [Related]
25. Immunomodulation and antitumor effects of MVE-2 in mice. Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720 [TBL] [Abstract][Full Text] [Related]
26. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions. Thatcher N; Swindell R; Crowther D Clin Exp Immunol; 1979 Feb; 35(2):171-9. PubMed ID: 312169 [TBL] [Abstract][Full Text] [Related]
27. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity. Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. Hanna N; Schneider M J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells. Zighelboim J; Lichtenstein A; Bick A; Mickel R Cancer Res; 1983 May; 43(5):1984-9. PubMed ID: 6339046 [TBL] [Abstract][Full Text] [Related]
30. In vitro augmentation of rat natural killer (NK) cell activity. Reynolds CW; Herberman RB J Immunol; 1981 Apr; 126(4):1581-5. PubMed ID: 6451648 [TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal administration of Corynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: effects on cytotoxicity of tumor-associated macrophages and NK cells. Mantovani A; Sessa C; Peri G; Allavena P; Introna M; Polentarutti N; Mangioni C Int J Cancer; 1981; 27(4):437-46. PubMed ID: 6168590 [No Abstract] [Full Text] [Related]
33. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages. Cohen DA; Bubel HC J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395 [TBL] [Abstract][Full Text] [Related]
34. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation. Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930 [TBL] [Abstract][Full Text] [Related]
36. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions. Thatcher N; Swindell R; Crowther D Clin Exp Immunol; 1979 May; 36(2):227-36. PubMed ID: 314367 [TBL] [Abstract][Full Text] [Related]
37. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
38. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type. Gray JD; Brooks CG; Baldwin RW Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794 [TBL] [Abstract][Full Text] [Related]
39. Comparative effects of different strains of Corynebacterium parvum on natural cell-mediated cytotoxicity. Nasrallah AG; Gallagher MT; Priest EL; Trentin JJ Cancer Res; 1980 Nov; 40(11):4159-64. PubMed ID: 7471057 [TBL] [Abstract][Full Text] [Related]
40. Induction and persistence in vivo of NK/LAK activity by a mannoprotein component of Candida albicans cell wall. Scaringi L; Cornacchione P; Rosati E; Fettucciari K; Rossi R; Marconi P Cell Immunol; 1994 May; 155(2):265-82. PubMed ID: 8181065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]